Diabetes Center, Institute of Clinical and Experimental Medicine
Prague, 14021, Czechia
NCT Number: NCT01011062
The study aims to investigate the effect of acute angiotensin receptor blockade on insulin action/insulin resistance and expressions of selected adipocytokines in subcutaneous adipose tissue in insulin-resistant subjects with type 2 diabetes and healthy controls.
Hypothesis: Changes in adipocytokine concentrations and/or expressions and different reactions to acute in vivo induced hyperinsulinemia and angiotensin receptor blockade will be found in patients with type 2 diabetes compared to healthy subjects. A significant relationships between insulin sensitivity and selected adipokines and intracellular fat content and high energy phosphates in soleus muscle will be documented in healthy individuals, while no significant relation will be found in patients with type 2 diabetes.
Looking for future studies?
Notify Me18 year–70 year
Male
Interventional
Not applicable
Prague, 14021, Czechia
10-15 patients with type 2 diabetes and 10-15 healthy control subjects will be examined on an outpatient basis. The following examination will be carried out in each subject after 12 hrs fasting:
Before (0 min), at 30 min and in the end of studies c) and d) the blood samples will be taken and biopsies of subcutaneous abdominal adipose tissue will be done.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Hyperinsulinaemic (1 mIU/kg/min) euglycaemic (5 mmol/l) clamp
Acute administration of losartan 200mg total prior to clamp
Infusion of Saline as a volume control intervention
Time frame: 4 hours
Time frame: at 0 and 240 min of the clamp
Institute for Clinical and Experimental Medicine
Other Gov
Effect of Acute Angiotensin Receptor Blockade on Insulin Resistance and Selected Cytokines in Adipose Tissue in Type 2 Diabetes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04167761
Arterial Occlusive Diseases, Arteriosclerosis
Stanford, California, United States
View Trial DetailsNCT07389122
Body Weight, Body Weight Changes
Bologna, BO, Italy
View Trial DetailsNCT04992299
Adolescent Development, Behavior
Aurora, Colorado, United States
View Trial DetailsNCT05314855
Diabetes Mellitus, Diabetes Mellitus, Type 2
Amsterdam, North Holland, Netherlands
View Trial Details